Innate Pharma (IPHA) Other Operating Expenses (2023 - 2025)

Innate Pharma (IPHA) has 3 years of Other Operating Expenses data on file, last reported at $1164.0 in Q4 2025.

• For the quarter ending Q4 2025, Other Operating Expenses changed N/A year-over-year to $1164.0; the trailing twelve-month figure through Dec 2025 stood at $2240.9 (up 108.09% YoY), and the FY2025 full-year result was -$1164.0, changed N/A from the prior year.
• Other Operating Expenses for Q4 2025 stood at $1164.0, up from -$0.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $1164.0 in Q4 2025 and bottomed at -$0.0 in Q2 2025.
• The 3-year median for Other Operating Expenses is $538.44 (2023), against an average of $560.23.
• The widest annual swing landed in 2024, when Other Operating Expenses surged 14453740380100.0%; it then sank 100.0% in 2025.
• A 3-year view of Other Operating Expenses shows it stood at $0.0 in 2023, then soared by 14453740380100.0% to $1076.9 in 2024, then grew by 8.09% to $1164.0 in 2025.
• The last three Other Operating Expenses figures came in at $1164.0 (Q4 2025), -$0.0 (Q2 2025), and $1076.9 (Q2 2024), per Business Quant data.

Peer Comparison